Crescent Biopharma, Inc. (CBIO)

NASDAQ: CBIO · Real-Time Price · USD

12.01

+0.72 (6.38%)

At close: Oct 8, 2025, 4:00 PM EDT

12.06

+0.05 (0.42%)

After-hours: Oct 8, 2025, 4:00 PM EDT

Company Description

Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates.

Its pipeline includes CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003.

The company is headquartered in Waltham, Massachusetts.

Crescent Biopharma, Inc.

Contact Details

Address: 300 Fifth Avenue Waltham, Massachusetts 02451 United States
Phone	617-430-5595
Website	crescentbiopharma.com

Name	Position
Joshua T. Brumm	Chief Executive Officer and Director
Dr. Jonathan McNeill M.D.	President and Chief Operating Officer
Richard William Scalzo M.B.A.	Chief Financial Officer
Ryan Lynch	Senior Vice President of Finance, Treasurer and Chief Accounting Officer
Dr. Jan Pinkas Ph.D.	Chief Scientific Officer
Barbara H. Bispham J.D.	General Counsel and Corporate Secretary
Amy Reilly	Chief Communications Officer
Christopher Doughty	Chief Business Officer
Dr. Wenjie Cheng Ph.D.	Senior Vice President of Technical Operations
Dr. Ellie Im M.D.	Chief Medical Officer